Anesth Analg 2002;94:1434-1440
© 2002 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
Dual 2-Adrenergic Agonist and 1-Adrenergic Antagonist Actions of Dexmedetomidine on Human Isolated Endothelium-Denuded Gastroepiploic Arteries
Junichirou Hamasaki, MD*,
Isao Tsuneyoshi, MD* ,
Rumi Katai, MD*,
Tatewaki Hidaka, MD*,
Walter A. Boyle, MD , and
Yuichi Kanmura, MD*
*Department of Anesthesiology and Critical Care Medicine, Kagoshima University School of Medicine, Japan; and Research Unit and Division of Critical Care, Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri
Address correspondence and reprint requests to Junichirou Hamasaki, MD, Department of Anesthesiology and Critical Care Medicine, Kagoshima University School of Medicine, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan. Address e-mail to hamasak1{at}m2.kufm.kagoshima-u.ac.jp
The actions of dexmedetomidine (DEX) on human vascular smooth muscle are unclear. We investigated its effects on isolated, endothelium-denuded human gastroepiploic arteries in vitro and compared them with clonidine (CLO). DEX had little direct effect on resting tension, whereas CLO produced small contractile responses, an effect which is blocked by the 1-adrenergic antagonist prazosin. DEX markedly enhanced the high K+ (40 mmol/L)-induced contraction, and this effect was reversed by the 2-adrenergic antagonists yohimbine and rauwolscine but unaffected by prazosin. However, CLO had little effect on the K+ contractions. Interestingly, larger concentrations (>10-7 mol/L) of both 2-adrenergic stimulants significantly inhibited the contractions elicited by the 1-adrenergic agonist phenylephrine (10-6 mol/L) and, to a lesser extent, those elicited by the 1/ 2-agonist norepinephrine (10-6 mol/L). These results suggest the possibility that DEX and CLO each have a high affinity for 1-adrenoceptors in human isolated gastroepiploic arteries, resulting in a reduced efficacy of 1-adrenergic activation by -agonists. The differing affinities of the drugs for 1- and 2-adrenoceptors may help explain their additional actions: 1) DEX enhances the high K+-induced contraction presumably through 2-adrenoceptor activation, and 2) CLO acts on 1-adrenoceptors as a partial agonist when present alone.
IMPLICATIONS: Dexmedetomidine may not directly affect smooth muscle in human peripheral resistance vessels within the usual range of plasma concentrations (<10-7 mol/L) achieved in clinical practice. However, in large doses, it could enhance the response to nonadrenergic vasoconstrictor agonists while antagonizing the vasoconstrictor response to 1-adrenoceptor agonists.
This article has been cited by other articles:

|
 |

|
 |
 
T. Yoshitomi, A. Kohjitani, S. Maeda, H. Higuchi, M. Shimada, and T. Miyawaki
Dexmedetomidine Enhances the Local Anesthetic Action of Lidocaine via an {alpha}-2A Adrenoceptor
Anesth. Analg.,
July 1, 2008;
107(1):
96 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Onomoto, I. Tsuneyoshi, A. Yonetani, S. Suehiro, K. Matsumoto, R. Sakata, and Y. Kanmura
Differential Pharmacologic Sensitivities of Phosphodiesterase-3 Inhibitors Among Human Isolated Gastroepiploic, Internal Mammary, and Radial Arteries
Anesth. Analg.,
October 1, 2005;
101(4):
950 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Masuki, F. A. Dinenno, M. J. Joyner, and J. H. Eisenach
Selective {alpha}2-adrenergic properties of dexmedetomidine over clonidine in the human forearm
J Appl Physiol,
August 1, 2005;
99(2):
587 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|